Eghbali Maryam, Cheraghi Sara, Samanian Sara, Rad Iman, Meghdadi Jafar, Akbari Hamideh, Honardoost Maryam
Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran 1593716615, Iran.
Genetic Foundation of Tehran, Solaleh Diagnostic Laboratory, Tehran 1393845944, Iran.
Diagnostics (Basel). 2022 Dec 2;12(12):3028. doi: 10.3390/diagnostics12123028.
Background: Primary macronodular adrenocortical hyperplasia (PMAH) is a rare form of adrenal Cushing’s syndrome with incomplete penetrance which may be sporadic or autosomal dominant. The inactivation of the ARMC5 gene, a potential tumor suppressor gene, is one of the associated causes of PMAH. This study aimed to identify the variant responsible for Iranian familial PMAH. Methods: The proband, a 44-year-old woman, was directed to whole-exome sequencing (WES) of the blood sample to discover a germline variant. In addition, the identified causative variant was confirmed and segregated in other and available unaffected family members. Results: The novel germline heterozygous missense variant, c.2105C>A in the ARMC5 gene, was found, and the same germline variant as the proband was confirmed in two affected sisters. This variant was detected in the brother of the proband with an asymptomatic condition and this considered because of incomplete penetrance and age-dependent appearance. The function of the ARMC5 protein would be damaged by the identified variant, according to in silico and computer analyses that followed. Conclusion: The new germline ARMC5 variation (c.2105C>A, (p. Ala702Glu)) was interpreted as a likely pathogenic variant based on ACMG and Sherloc standards. PMAH may be diagnosed early using genetic testing that shows inherited autosomal dominant mutations in the ARMC5 gene.
原发性大结节性肾上腺皮质增生(PMAH)是肾上腺库欣综合征的一种罕见形式,具有不完全外显率,可能为散发性或常染色体显性遗传。ARMC5基因作为一种潜在的肿瘤抑制基因,其失活是PMAH的相关病因之一。本研究旨在鉴定导致伊朗家族性PMAH的变异。方法:先证者为一名44岁女性,对其血液样本进行全外显子测序(WES)以发现种系变异。此外,对已鉴定的致病变异在其他可获得的未受影响家庭成员中进行确认和分离分析。结果:发现了ARMC5基因中的新型种系杂合错义变异c.2105C>A,并在两名受影响的姐妹中确认了与先证者相同的种系变异。在先证者的无症状兄弟中也检测到了该变异,这被认为是由于不完全外显率和年龄依赖性表现所致。根据后续的计算机模拟和分析,已鉴定的变异会损害ARMC5蛋白的功能。结论:根据美国医学遗传学与基因组学学会(ACMG)和Sherloc标准,新的种系ARMC5变异(c.2105C>A,(p.Ala702Glu))被解释为可能的致病变异。使用基因检测可早期诊断PMAH,该检测显示ARMC5基因存在遗传性常染色体显性突变。